Get access to our best features
Get access to our best features
Published 2 years ago

U.S. Novabax will launch Omicron-derived compatible vaccine in the fourth quarter

Summary
[1st Reuters] - US biopharmaceutical company Novavax is accelerating the development of vaccines corresponding to the derivative types “BA.4" and “BA.5" of the omicron variants of the novel coronavirus vaccine on the 1st. It showed the prospect that it could be provided in the fourth quarter.

0 Articles

All
Left
Center
Right
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe
Ground News Article Assistant
Not enough coverage to generate an Article Assistant.

Bias Distribution

  • 100% of the sources are Center
100% Center
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

Sources are mostly out of (0)